BIOTECHNOLOGY VALUE FUND L P - 30 Jun 2025 SCHEDULE 13G/A Report for IMMUNIC, INC. Common Stock, $0.0001 par value (IMUX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
IMMUNIC, INC. Common Stock, $0.0001 par value
Symbol
IMUX
Shares outstanding
97,949,730 shares
Disclosed Ownership
9,785,178 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:02:46 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 6.4% 6,268,162 0 6,268,162 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 6.4% 6,268,162 0 6,268,162 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3.2% 3,027,105 0 3,027,105 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3.2% 3,027,105 0 3,027,105 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.3% 315,231 0 315,231 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.3% 315,231 0 315,231 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.5% 9,295,267 0 9,295,267 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 10% 9,785,178 0 9,785,178 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 10% 9,785,178 0 9,785,178 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 10% 9,785,178 0 9,785,178 /s/ Mark N. Lampert Mark N. Lampert